Skip to main content
OpenTrials
Completed

NCT Number: NCT05232058

FRENCH OBSERVATORY OF ACUTE HEART FAILURE-2

In 2009, OFICA 1 provided a snapshot of the management of acute heart failure in France.

Over the past 10 years, practitioners have observed a change in the profiles of hospitalized patients and it is necessary to specify the evolution of these characteristics, especially since the recommendations concerning management have changed significantly; this is the objective of this observatory.

Like patients suffering from chronic diseases such as diabetes or asthma, heart failure patients are therefore at the center of their management. Compliance is improved when patients have understood the reason for the prescription. Ideally, compliance should not be achieved by respecting externally imposed norms, but rather by respecting norms that are understood, adapted, personalized and accepted.

A self-questionnaire will thus be given to patients on the day of inclusion in the study.

In heart failure patients with an average age of 80 years, systematic screening for cognitive disorders using a simple test recommended by the French National Authority for Health (Haute Autorité de Santé), the codex test, will make it possible to offer more appropriate care if necessary (geriatric or neurology consultation).

Finally, follow-up at 3 months and at 1 and 2 years will be carried out by matching with data from the National Health Data System (SNDS)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Heart Failure Cardiovascular Diseases Heart Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Lariboisière, APHP

Paris, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient hospitalized, regardless of the initial mode of admission, with acute heart failure (de novo heart failure or decompensation of chronic heart failure) of any severity and corresponding to one of the following clinical situations :
  • Pulmonary edema, hypertensive or not
  • Congestive heart failure (pulmonary congestion, peripheral oedema)
  • Cardiogenic shock
  • High output heart failure
  • Isolated right heart failure
  • Patient who agreed to participate in the study

Exclusion criteria

  • Expressed refusal to participate in the study
  • Scheduled hospitalization for assessment
  • Surgical context (immediate postoperative period)
  • Diagnosis of acute heart failure reversed to another diagnosis before end of hospitalization

Treatment and study plan

Primary outcomes

  1. Analyze survival during hospitalization

    Time frame: Trough length of hospitalization, an average of 10 days

    Rate of death during hospitalizaton

Secondary outcomes

  1. Analyze survival at 2 years after hospitalisation

    Time frame: 2 years after hospitalisation

    Rate of death at 2 years

Sponsors and collaborators

Lead sponsor

French Cardiology Society

Other

Registry information

Acronym: OFICA2

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Feb 9, 2022
Registry last updated
Feb 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.